AR041536A1 - Derivados metaestables de benzoxepina que pueden ser usados en el tratamiento de dislipidemia, ateroesclerosis y diabetes, composiciones farmaceuticas que los contienen y procedimientos para su preparacion - Google Patents

Derivados metaestables de benzoxepina que pueden ser usados en el tratamiento de dislipidemia, ateroesclerosis y diabetes, composiciones farmaceuticas que los contienen y procedimientos para su preparacion

Info

Publication number
AR041536A1
AR041536A1 ARP030103639A ARP030103639A AR041536A1 AR 041536 A1 AR041536 A1 AR 041536A1 AR P030103639 A ARP030103639 A AR P030103639A AR P030103639 A ARP030103639 A AR P030103639A AR 041536 A1 AR041536 A1 AR 041536A1
Authority
AR
Argentina
Prior art keywords
metastable
aterosclerosis
benzoxepin
dyslipidemia
diabetes
Prior art date
Application number
ARP030103639A
Other languages
English (en)
Inventor
Nathalie Bosc
Bernard Boudet
Festal Didier Dr
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of AR041536A1 publication Critical patent/AR041536A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Reivindicación 1: Forma metaestable de los compuestos de fórmula 1, en la cual: n representa 0, 1 ó 2; y los radicales R, los cuales pueden ser idénticos o diferentes, son grupos alquilo o alcoxi, o átomos de halógeno.
ARP030103639A 2002-10-07 2003-10-07 Derivados metaestables de benzoxepina que pueden ser usados en el tratamiento de dislipidemia, ateroesclerosis y diabetes, composiciones farmaceuticas que los contienen y procedimientos para su preparacion AR041536A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0212432A FR2845386B1 (fr) 2002-10-07 2002-10-07 Nouveaux derives metastables de benzoxepines utilisables dans le traitement des dyslipidemies, de l'atherosclerose et du diabete, compositions pharmaceutiques les contenant et procedes de preparation

Publications (1)

Publication Number Publication Date
AR041536A1 true AR041536A1 (es) 2005-05-18

Family

ID=32011471

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030103639A AR041536A1 (es) 2002-10-07 2003-10-07 Derivados metaestables de benzoxepina que pueden ser usados en el tratamiento de dislipidemia, ateroesclerosis y diabetes, composiciones farmaceuticas que los contienen y procedimientos para su preparacion

Country Status (8)

Country Link
US (1) US7470719B2 (es)
EP (1) EP1549630A1 (es)
JP (1) JP4856376B2 (es)
AR (1) AR041536A1 (es)
AU (1) AU2003264139B2 (es)
CA (1) CA2502877C (es)
FR (1) FR2845386B1 (es)
WO (1) WO2004031166A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2845386B1 (fr) 2002-10-07 2006-06-30 Merck Sante Sas Nouveaux derives metastables de benzoxepines utilisables dans le traitement des dyslipidemies, de l'atherosclerose et du diabete, compositions pharmaceutiques les contenant et procedes de preparation
CA3021953C (en) 2005-04-20 2022-11-01 Bgc Partners, Inc. Systems and methods for maintaining the viability of a good-until-bettered order type in electronic trading systems
EP2309974B1 (en) * 2008-08-12 2016-08-31 Merck Patent GmbH Use of 5-(7-methoxy-3,3-dimethyl-2,3-dihydro-1-benzoxepin-5-yl)-3-methyl-penta-2,4-dienoic

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2787789B1 (fr) * 1998-12-29 2002-06-14 Lipha Benzopyranes et benzoxepines utilisables dans le traitement de dyslipidemies, de l'atherosclerose et du diabete, compositions pharmaceutiques les contenant et procedes de preparations
FR2845386B1 (fr) 2002-10-07 2006-06-30 Merck Sante Sas Nouveaux derives metastables de benzoxepines utilisables dans le traitement des dyslipidemies, de l'atherosclerose et du diabete, compositions pharmaceutiques les contenant et procedes de preparation

Also Published As

Publication number Publication date
JP2006503073A (ja) 2006-01-26
AU2003264139B2 (en) 2009-09-03
US7470719B2 (en) 2008-12-30
FR2845386B1 (fr) 2006-06-30
CA2502877A1 (en) 2004-04-15
AU2003264139A1 (en) 2004-04-23
CA2502877C (en) 2011-07-26
EP1549630A1 (en) 2005-07-06
JP4856376B2 (ja) 2012-01-18
WO2004031166A1 (en) 2004-04-15
US20060041007A1 (en) 2006-02-23
FR2845386A1 (fr) 2004-04-09

Similar Documents

Publication Publication Date Title
CY1112084T1 (el) Παραγωγα 5-φαινυλθειαζολης και χρηση ως αναστολεις της κινασης ρi3
SV2004001690A (es) Nuevos derivados de fluoroglicosidos heterociclicos, medicamentos que contienen estos compuestos, y el uso de los mismos
BR0308452A (pt) composições farmacêuticas e métodos de preparação de composição farmacêutica
ECSP045004A (es) Inhibidores de la 17beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades andrógeno dependientes
PA8537501A1 (es) Naftostirilos
CY1105349T1 (el) Θειαζολυλ-αναστολεις τυροκινασεων της οικογενειας tec
UY28342A1 (es) Nuevos compuestos
CY1108408T1 (el) Παραγωγα διαζεπινοϊνδολιου ως αναστολεις κινασης
CY1107301T1 (el) Ιμιδαζο και θειαζολοπυριδινες ως αναστολεις κινασης jak3
ECSP088598A (es) Derivados de piridazinona
UY27234A1 (es) Inhibidores novedosos de tirosina cinasa
PL1899329T3 (pl) Pirymidyno-podstawione pochodne benzimidazolu jako inhibitory kinaz białkowych
ECSP055640A (es) Composiciones de pirazol útiles como inhibidores de gsk-3
AR071120A1 (es) Derivados de diosmetina, su procedimiento de preparacion, las composiciones farmaceuticas que los contienen y su uso en el tratamiento de las enfermedades venosas cronicas.
UY29518A1 (es) Derivados de alquil-, alquenil- y alquinilcarbamatos, su preparación y su aplicación en terapéutica.
GT200600161A (es) Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de los trastornos psicoticos
ECSP066484A (es) Compuestos y metodos para el tratamiento de dislipidemia
NO20054340L (no) Nye sammenkoplede heterocykler og deres anvendelse
SE0302139D0 (sv) Novel compounds
ECSP056006A (es) Composiciones farmacéuticas que comprenden una combinación de rapamicina o su derivado y pimecrolimus para el tratamiento de enfermedades inflamatorias e inmunológicamente mediadas
PL376324A1 (en) Piperazinyl and diazapanyl benzamides and benzthioamides
MXPA04002042A (es) Compuestos de bencimidazol sustituidos y su uso para el tratamiento del cancer.
AR021843A1 (es) Derivados de propanolamina sustituidos con heterociclos, procedimiento para su preparacion, y su utilizacion.
DK1313740T3 (da) Prodrugs af imidazopyridinderivater
BR0109512A (pt) Imidazopiridinas tricìclicas

Legal Events

Date Code Title Description
FA Abandonment or withdrawal